Abraham Mary, Khosroshahi Arezou
a Department of Medicine, Division of Rheumatology , Emory University School of Medicine , Atlanta , GA , USA.
Expert Rev Clin Immunol. 2017 Sep;13(9):867-875. doi: 10.1080/1744666X.2017.1354698. Epub 2017 Jul 24.
IgG4-Related Disease is a newly recognized condition which is increasingly diagnosed by practitioners due to improvement in clinical awareness. Men and women have been found to be affected by this disease in various organs, more commonly with involvement of the salivary and lacrimal glands as well as pancreas and liver. Areas covered: The diagnosis and management of this condition remain challenging as biomarkers and therapies are being investigated. Hallmark features on histology are still the gold standard for confirmation of diagnosis, whereas serum IgG4 level has been shown to be neither necessary nor sufficient for the diagnosis. Glucocorticoids remain the most effective initial management for this condition while there are limited clinical trials on the effectiveness of maintenance therapy. Expert commentary: This review serves as an update on approaches for diagnosis and management of IgG4-RD. Most of the known data in this field comes from retrospective cohort studies and expert consensus guidelines but new ongoing prospective studies, clinical trials and better understanding of the pathogenesis of this condition are promising.
IgG4相关性疾病是一种新认识的疾病,由于临床认知的提高,从业者对其诊断越来越多。已发现男性和女性的各个器官均可受此病影响,更常见的是累及唾液腺、泪腺以及胰腺和肝脏。涵盖领域:由于正在研究生物标志物和治疗方法,这种疾病的诊断和管理仍然具有挑战性。组织学上的标志性特征仍是确诊的金标准,而血清IgG4水平已被证明对诊断既非必要条件也非充分条件。糖皮质激素仍然是这种疾病最有效的初始治疗方法,而关于维持治疗有效性的临床试验有限。专家评论:本综述是对IgG4相关性疾病诊断和管理方法的更新。该领域的大多数已知数据来自回顾性队列研究和专家共识指南,但正在进行的新的前瞻性研究、临床试验以及对该疾病发病机制的更好理解前景广阔。